OKITA, R., SHIMIZU, K., NOJIMA, Y., YUKAWA, T., MAEDA, A., SAISHO, S., & NAKATA, M. (2015). Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells. Oncol Rep.
Citação norma ChicagoOKITA, RIKI, KATSUHIKO SHIMIZU, YUJI NOJIMA, TAKURO YUKAWA, AI MAEDA, SHINSUKE SAISHO, and MASAO NAKATA. "Lapatinib Enhances Trastuzumab-mediated Antibody-dependent Cellular Cytotoxicity Via Upregulation of HER2 in Malignant Mesothelioma Cells." Oncol Rep 2015.
ציטוט MLAOKITA, RIKI, et al. "Lapatinib Enhances Trastuzumab-mediated Antibody-dependent Cellular Cytotoxicity Via Upregulation of HER2 in Malignant Mesothelioma Cells." Oncol Rep 2015.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.